Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue Critical Care Année : 2022

Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors

Dates et versions

hal-03837954 , version 1 (03-11-2022)

Identifiants

Citer

Hadrien Winiszewski, Gael Piton, Gilles Capellier, Mouhamed Djahoum Moussa, Christophe Beyls, et al.. Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors. Critical Care, 2022, 26 (1), ⟨10.1186/s13054-022-04181-z⟩. ⟨hal-03837954⟩
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More